Business

Amazon's autonomous vehicle unit, Zoox, announced plans to test-drive "robotaxis" in downtown Seattle. NPR's David Folkenflik speaks with historian Peter Norton.

NPR's David Folkenflik speaks with B.Pagels Minor, a former Netflix employee, about their firing and the controversy surrounding the streamer's release of Dave Chappelle's latest stand up special.

For $3.5 million, you can roam the halls of the Los Angeles house where Freddie Krueger murdered his victims. You have until Halloween to make an offer.

President Biden has said he's open to compromise on his plans to expand the social safety, but some advocates are concerned that access to benefits may be too limited.

Internal Facebook documents show how the pro-Trump Stop the Steal movement proliferated on the world's biggest social network between the presidential election and the Jan. 6 insurrection.

Officials are looking into four confirmed cases of the dangerous bacteria discovered in the sprays. Two deaths associated with the bacteria are being investigated.

Traditionally, brands rarely mention their competitors, and if they do it's likely to attack them. But one study shows how brands praising their competitors might actually help boost their sales.

NPR's Audie Cornish talks with Rachel Abrams, a lawyer representing victims of sexual assault in lawsuits against rideshare company Lyft, which had over 4,000 reports of sexual assault in two years.

The Biden administration hopes to help fund its agenda by cracking down on tax evasion, spotting cheats using account information from banks. It's drawing opposition from GOP lawmakers and banks.

Some landlords got hurt by tenants who took advantage of eviction bans during the pandemic. Now they can't get any help from a massive $47 billion federal rental assistance program.

More and more tech workers are publicly criticizing their companies. But those who have spoken out say it's taken a toll on their careers, friendships and mental health.

The companies studied a 10 microgram vaccine dose in children 5 to 11, a third of the dose used for adults, to minimize side effects and because it still prompts a strong immune response.